Companies / LLY vs VTRS
LLY vs VTRS: Eli Lilly and Viatris
Eli Lilly (LLY) reported $65.2B in revenue against a 31.7% net margin, while Viatris (VTRS) reported $14.3B at a -24.6% net margin, most recently.
| Metric | LLY | VTRS |
|---|---|---|
| Revenue | $65.2B | $14.3B |
| Net Income | $20.6B | $-3.5B |
| Gross Margin | 83.0% | 35.1% |
| Operating Margin | — | -18.6% |
| EPS (Diluted) | $22.95 | $-3.00 |
| Free Cash Flow | — | $1.9B |
| Total Debt | $42.5B | $14.4B |
| P/E Ratio | 46.9× | n/m |
| P/B Ratio | n/m | n/m |
| Stock Price | $1375.19 | $19.00 |
Free: last 5 years
| Fiscal year | FY2018 🔒 | FY2019 🔒 | FY2020 🔒 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| LLY Revenue | ••••• | ••••• | ••••• | $28.3B | $28.5B | $34.1B | $45.0B | $65.2B |
| VTRS Revenue | ••••• | ••••• | ••••• | $17.9B | $16.3B | $15.4B | $14.7B | $14.3B |